Charles River Laboratories International, Inc announced the launch of Accugenix® Next Generation Sequencing for Bacterial Identification and Fungal Identification. Accugenix NGS simultaneously sequences millions of individual DNA fragments from a sample and provides key information to pharmaceutical and personal care manufacturers regarding microbial control. When studying pure isolates and/or sequencing of mixed species environments, Accugenix […]
Related Articles
This post first appeared on Leading Pharmaceutical Industry Online Platform, please read the originial post: here